The effect of MICA antigens on kidney transplantation outcomes

Immunology Letters

Volumn 156, Issue 1-2, 2013, Pages 54-58

  Luo, Lei ^a   Li, Zhengyu ^a   Wu, Weidong ^a   Luo, Guangheng ^a   Mei, Hong ^a   Sun, Zhaolin ^a   Xu, Chuan ^a  

^a Guizhou Province People's Hospital   (China)

Author keywords

Allografts rejection; Allografts survival; Kidney transplantation; Major histocompatibility complex class I related antigens A

Indexed keywords

HLA A ANTIGEN; HLA ANTIBODY;

ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ENDOTHELIUM CELL; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GRAFT SURVIVAL; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MICA GENE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SURGICAL RISK; TREATMENT OUTCOME;

ALLOGRAFTS REJECTION; ALLOGRAFTS SURVIVAL; KIDNEY TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-RELATED ANTIGENS A;

ANTIBODIES; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84885733707     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2013.08.009     Document Type: Review

References (37)

1. Sumitran-Holgersson S. Relevance of MICA and other non-HLA antibodies in clinical transplantation. Curr Opin Immunol 2008, 20(5):607-613.
2. Kissmeyer-Nielsen F., Olsen S., Petersen V.P., Fjeldborg O. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet 1966, 2(7465):662-665.
3. van der Mast B.J., van Besouw N.M., Witvliet M.D., de Kuiper P., Smak Gregoor P., van Gelder T., et al. Formation of donor-specific human leukocyte antigen antibodies after kidney transplantation: correlation with acute rejection and tapering of immunosuppression. Transplantation 2003, 75(6):871-877.
4. Kayler L.K., Farber J.L., Colombe B., LaCava D., Friedewald J.J., Ratner L.E. Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation. Transpl Int 2006, 19(2):128-139.
5. Sumitran-Karuppan S., Tyden G., Reinholt F., Berg U., Moller E. Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells. Transpl Immunol 1997, 5(4):321-327.
6. Mizutani K., Terasaki P.I., Shih R.N., Pei R., Ozawa M., Lee J. Frequency of MIC antibody in rejected renal transplant patients without HLA antibody. Hum Immunol 2006, 67(3):223-229.
7. Pierce J.C., Waller M., Phibbs M. A mixed antiglobulin test with kidney cells in suspension for IgG antibody in human allograft recipients. Transplantation 1975, 19(4):343-348.
8. Bahram S., Bresnahan M., Geraghty D.E., Spies T. A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci U S A 1994, 91(14):6259-6263.
9. Zhang Y., Han M., Vorhaben R., Giang C., Lavingia B., Stastny P. Study of MICA alleles in 201 African Americans by multiplexed single nucleotide extension (MSNE) typing. Hum Immunol 2003, 64(1):130-136.
10. Lucas D., Campillo J.A., López-Hernández R., Martínez-García P., López-Sánchez M., Botella C., et al. Allelic diversity of MICA gene and MICA/HLA-B haplotypic variation in a population of the Murcia region in southeastern Spain. Hum Immunol 2008, 69(10):655-660.
11. Zhu F., Zhao H., He Y., Zhang W., He J., Xu X., et al. Distribution of MICA diversity in the Chinese Han population by polymerase chain reaction sequence-based typing for exons 2-6. Tissue Antigens 2009, 73(4):358-363.
12. Katsuyama Y., Ota M., Ando H., Saito S., Mizuki N., Kera J., et al. Sequencing based typing for genetic polymorphisms in exons, 2, 3 and 4 of the MICA gene. Tissue Antigens 1999, 54(2):178-184.
13. Sohn Y.H., Cha C.H., Oh H.B., Kim M.H., Choi S.E., Kwon O.J. MICA polymorphisms and haplotypes with HLA-B and HLA-DRB1 in Koreans. Tissue Antigens 2010, 75(1):48-55.
14. Romphruk A.V., Naruse T.K., Romphruk A., Kawata H., Puapairoj C., Kulski J.K., et al. Diversity of MICA (PERB11.1) and HLA haplotypes in Northeastern Thais. Tissue Antigens 2001, 58(2):83-89.
15. Bahram S., Spies T. Nucleotide sequence of a human MHC class I MICB cDNA. Immunogenetics 1996, 43(4):230-233.
16. Zou Y., Heinemann F.M., Grosse-Wilde H., Sireci G., Wang Z., Lavingia B., et al. Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by luminex flow cytometry. Hum Immunol 2006, 67(3):230-237.
17. Lemy A., Andrien M., Wissing K.M., Ryhahi K., Vandersarren A., Racapé J., et al. Major histocompatibility complex class 1 chain-related antigen A antibodies: sensitizing events and impact on renal graft outcomes. Transplantation 2010, 90(2):168-174.
18. Solgi G., Furst D., Mytilineos J., Pourmand G., Amirzargar A.A. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA. Transpl Immunol 2012, 26(2-3):81-87.
19. Yu L.X., Gui W., Fu S.J., et al. Anti-MICA antibodies: risk factors for sensitization and the impact on renal transplantation outcomes. J South Med Univ. 2011, 31(4):615-618.
20. Panigrahi A., Gupta N., Siddiqui J.A., Margoob A., Bhowmik D., Guleria S., et al. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss. Hum Immunol 2007, 68(5):362-367.
21. Suárez-Alvarez B., Alonso-Arias R., Bravo-Mendoza C., et al. Identification of epitopes and immunodominant regions on the MICA protein defined by alloantibodies from kidney transplant patients. Transplantation 2009, 88:S68-S77.
22. Li Z., Luo M., Qiu J., Liu Y., Fan Y., Jahr F.M., et al. Detection of antibodies against major histocompatibility complex class I-related chain A in long-term renal graft recipients. Exp Clin Transplant 2012, 10(3):239-242.
23. Yao Q.C., Wang W., Li X.B., Yin H., Zhang X.D. Expression characteristics of major histocompatibility complex class I-related chain A antibodies and immunoadsorption effect in sensitized recipients of kidney transplantation. Chin Med J (Engl) 2011, 124(5):669-673.
24. Yu Lixin, Zhang Xinke, Luo Min, et al. Impact of MICA antibodies on acute graft rejection early after kidney transplantation. J South Med Univ 2012, 32(5):651-654.
25. Zou Y., Stastny P. Role of MICA in the immune response to transplants. Tissue Antigens 2010, 76(3):171-176.
26. Molinero L.L., Domaica C.I., Fuertes M.B., Girart M.V., Rossi L.E., Zwirner N.W. Intracellular expression of MICA in activated CD4T lymphocytes and protection from NK cell-mediated MICA dependent cytotoxicity. Hum Immunol 2006, 67(3):170-182.
27. Hankey K.G., Drachenberg C.B., Papadimitriou J.C., Klassen D.K., Philosophe B., Bartlett S.T., et al. MIC expression in renal and pancreatic allografts. Transplantation 2002, 73(2):304-306.
28. Seyhun Y., Ozdilli K., Oguz F., Karahan G., Onal E., Turkmen A., et al. Human leukocyte antigen and major histocompatibility complex class I-related chain A antibodies after kidney transplantation in Turkish renal transplant recipients. Transplant Proc 2012, 44(6):1660-1666.
29. Lemy A., Andrien M., Lionet A., Labalette M., Noel C., Hiesse C., et al. Posttransplant major histocompatibility complex class I chain-related gene A antibodies and long-term graft outcomes in a multicenter cohort of 779 kidney transplant recipients. Transplantation 2012, 93(12):1258-1264.
30. Cox S.T., Stephens H.A., Fernando R., et al. Major histocompatibility complex class I-related chain A allele mismatching, antibodies, and rejection in renal transplantation. Hum Immunol 2011, 72:827-834.
31. Cecka J.M. The OPTN/UNOS renal transplant registry. Clin Transpl 2004, 1-16.
32. Terasaki P.I., Ozawa M., Castro R. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant 2007, 7(2):408-415.
33. Mizutani K., Terasaki P., Rosen A., Esquenazi V., Miller J., Shih R.N., et al. Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure. Am J Transplant 2005, 5(9):2265-2272.
34. Sumitran-holgersson S., Wilczed H.E., Holgersson J., et al. Identification of the nonclassical HLA molecules MICA, as targets for humoral immunity associated with irreversible rejection of kidney allografts. Transplantaion 2002, 74(2):268-277.
35. Zou Y., Stastny P., Süsal C., Döhler B., Opelz G. Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med. 2007, 357(13):1293-1300.
36. Bordron A., Dueymes M., Levy Y., Jamin C., Leroy J.P., Piette J.C., et al. The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. J Clin Invest 1998, 101:2029-2035.
37. Goers T.A., Ramachandran S., Aloush A., Trulock E., Patterson G.A., Mohanakumar T. De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection. J Immunol 2008, 180:4487-4494.